Table 1.
Patient characteristics and treatment aspects in 74 patients treated for AL after Ivor Lewis esophagectomy at Oslo University Hospital from 2010 to 2021
| Descriptive data and histology. | ||||||
|---|---|---|---|---|---|---|
| All patients (n = 74) | EVT (n = 6) | Stent (n = 40) | EVT + stent (n = 14) | Conservative (n = 12) | Other (n = 2) | |
| Age (median) | 66 | 72 | 66 | 68.5 | 66 | 59 |
| Sex (men) | 63 | 6 | 33 | 13 | 10 | 1 |
| ASA (median) | 2 | 2 | 2 | 2 | 3 | 2 |
| COPD | 13 (18%) | 0 | 6 (15%) | 4 (29) | 3 (25%) | 0 |
| Frailty score (median) | 3 | 3 | 3 | 2 | 3 | 3 |
| Diabetes | 12 (16%) | 2 (33%) | 7 (18%) | 1 (7%) | 2 (17%) | 0 |
| Smoking | 29 (39%) | 1 (17%) | 17 (43%) | 4 (29%) | 6 (50%) | 1 (50%) |
| HMIE | 4 (5%) | 0 | 4 (10%) | 0 | 0 | 0 |
| TMIE | 70 (95%) | 6 (100%) | 36 (90%) | 14 (100%) | 12 (100%) | 2 (100%) |
| Neoadjuvant radiochemotherapy | 27 (37%) | 1 (17%) | 18 (45%) | 5 (36%) | 3 (25%) | 0 |
| Neoadjuvant chemotherapy | 25 (34%) | 1 (17%) | 13 (33%) | 5 (36%) | 4 (33%) | 2 (100%) |
| Stapled end-side anastomosis (circular) | 72 (97%) | 6 (100%) | 38 (95%) | 14 (100%) | 12 (100%) | 2 (100%) |
| Stapled side-side anastomosis (straight) | 2 (3%) | 0 | 2 (5%) | 0 | 0 | 0 |
| FEV1 (% Predicted) | 67.5 | 83.3 | 53.2 | 88.5 | 70.9 | 87.0 |
| DLCO (% Predicted) | 66.0 | 81.6 | 48.1 | 96.6 | 71.0 | 74.0 |
| Histology | ||||||
| Adenocarcinoma | 61 (82%) | 5 (83%) | 34 (85%) | 12 (86%) | 8 (67%) | 2 (100%) |
| Squamous cell carcinoma | 10 (14%) | 0 | 6 (15%) | 1 (7%) | 3 (25%) | 0 |
| Other | 3 (4%) | 1 (17%) | 0 | 1 (7%) | 1 (8%) | 0 |
ASA, American Society of Anesthesiologists Physical Status; COPD, chronic obstructive pulmonary disease; HMIE, hybrid minimally invasive esophagectomy; TMIE, totally minimally invasive esophagectomy; EVT, endoscopic vacuum therapy